Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention

PS Chan, BK Nallamothu, JA Spertus… - … Quality and Outcomes, 2009 - Am Heart Assoc
Background—Although implantable cardioverter-defibrillators (ICDs) reduce mortality in
primary prevention patients with left ventricular systolic dysfunction, recent studies have …

Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary …

FA Masoudi, AS Go, DJ Magid… - … Quality and Outcomes, 2012 - Am Heart Assoc
Background—Implantable cardioverter-defibrillators (ICDs) are increasingly used for primary
prevention after randomized, controlled trials demonstrating that they reduce the risk of …

Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with nonischemic systolic heart failure

MB Elming, JC Nielsen, J Haarbo, L Videbæk… - Circulation, 2017 - Am Heart Assoc
Background: The DANISH study (Danish Study to Assess the Efficacy of ICDs [Implantable
Cardioverter Defibrillators] in Patients With Non-Ischemic Systolic Heart Failure on Mortality) …

Association between use of primary-prevention implantable cardioverter-defibrillators and mortality in patients with heart failure: a prospective propensity score …

B Schrage, A Uijl, L Benson, D Westermann… - Circulation, 2019 - Am Heart Assoc
Background: Most randomized trials on implantable cardioverter-defibrillator (ICD) use for
primary prevention of sudden cardiac death in heart failure with reduced ejection fraction …

Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit

R Parkash, JL Sapp, M Basta, S Doucette… - Circulation …, 2012 - Am Heart Assoc
Background—Underuse of implantable defibrillators has been previously noted in patients
at risk for sudden cardiac death, as well as for survivors of sudden cardiac death. We sought …

Cost-effectiveness of implantable cardioverter–defibrillators

GD Sanders, MA Hlatky, DK Owens - New England Journal of …, 2005 - Mass Medical Soc
Background Eight randomized trials have evaluated whether the prophylactic use of an
implantable cardioverter–defibrillator (ICD) improves survival among patients who are at risk …

New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: a pooled analysis of 4 randomized controlled …

DJ Friedman, SM Al-Khatib, EP Zeitler, JY Han… - American heart …, 2017 - Elsevier
Background Primary prevention implantable cardioverter defibrillator (ICD) reduce all-cause
mortality by reducing sudden cardiac death. There are conflicting data regarding whether …

Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study

MT Koller, B Schaer, M Wolbers, C Sticherling… - Circulation, 2008 - Am Heart Assoc
Background—Implantable cardioverter-defibrillators (ICDs) improve survival in selected
patients with left ventricular systolic dysfunction in randomized trials. Competing death …

Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 …

MJ Shun-Shin, SL Zheng, GD Cole… - European heart …, 2017 - academic.oup.com
Aims Primary prevention implantable cardioverter defibrillators (ICDs) are established
therapy for reducing mortality in patients with left ventricular systolic dysfunction and …

Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study

M Zabel, R Willems, A Lubinski, A Bauer… - European heart …, 2020 - academic.oup.com
Abstract Aims The EUropean Comparative Effectiveness Research to Assess the Use of
Primary ProphylacTic Implantable Cardioverter-Defibrillators (EU-CERT-ICD), a prospective …